Cardiac Output, Low
2
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
2
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Sharp TherapeuticsPA - Pittsburgh
1 programChanges in Cardiac Output During Delayed Umbilical Cord ClampingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Orion PharmaLevosimendan
Sharp TherapeuticsChanges in Cardiac Output During Delayed Umbilical Cord Clamping
Clinical Trials (2)
Total enrollment: 320 patients across 2 trials
Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS)
Start: Jun 2020Est. completion: Dec 2022300 patients
Phase 2/3Unknown
Changes in Cardiac Output During Delayed Umbilical Cord Clamping
Start: Jul 2014Est. completion: Dec 201420 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.